Solid Biosciences logo

Solid Biosciences

Solid Biosciences is a Cambridge, Massachusetts-based biotechnology company focused on solving Duchenne muscular dystrophy.

7

Funding Rounds

$426.3m

Money raised

Overview

Solid Biosciences is a Cambridge, Massachusetts-based biotechnology company focused on solving Duchenne muscular dystrophy.

Funding

Funding series

Funding Series Analysis

The company Solid Biosciences has raised a total of $222.5m in funding over 7 rounds.

Key Insights:

  • Solid Biosciences Venture round, December 11, 2020: $90m
  • Solid Biosciences Venture round, October 23, 2020: $40m
  • Solid Biosciences funding round, March 2017: $50m
  • Solid Biosciences Series B round, November 3, 2015: $42.5m
  • Solid Biosciences Venture round, March 2021: $143.8m
  • Solid Biosciences Inc. funding round, July 2019: $59.98m
Solid Biosciences logo
Solid Biosciences Venture round, December 11, 2020 $90m
Solid Biosciences logo
Solid Biosciences Venture round, October 23, 2020 $40m
Solid Biosciences logo
Solid Biosciences funding round, March 2017 $50m
Solid Biosciences logo
Solid Biosciences Series B round, November 3, 2015 $42.5m
Solid Biosciences logo
Solid Biosciences Venture round, March 2021 $143.8m
Solid Biosciences logo
Solid Biosciences Inc. funding round, July 2019 $59.98m

Industries

Solid Biosciences is active in the following industries:
  • Biotechnology
  • Healthcare
  • Biology
  • Tissue engineering
  • Biomedical engineering
  • Engineering
  • Biopharmaceutical
  • Regenerative medicine
  • Technology